Natural history of LGMD2A for delineating outcome measures in clinical trials

Evaluation of heart involvement in calpainopathy (LGMD2A) using cardiovascular magnetic resonance

(2015) Silvio Quick et al.   MUSCLE & NERVE

Upper Limb Strength and Function Changes during a One-Year Follow-Up in Non-Ambulant Patients with Duchenne Muscular Dystrophy: An Observational Multicenter Trial

(2015) Andreea Mihaela Seferian et al.   PLoS One

Gender difference in limb-girdle muscular dystrophy: a muscle fiber morphometric study in 101 patients

(2014) Marina Fanin et al.   CLINICAL NEUROPATHOLOGY

Muscle-specific calpain-3 is phosphorylated in its unique insertion region for enrichment in a myofibril fraction

(2014) Koichi Ojima et al.   GENES TO CELLS

Impaired calcium calmodulin kinase signaling and muscle adaptation response in the absence of calpain 3

(2012) I. Kramerova et al.   HUMAN MOLECULAR GENETICS

Genetic variability and clinical spectrum of Chinese patients with limb-girdle muscular dystrophy type 2A

(2012) Su-Shan Luo et al.   MUSCLE & NERVE

Reliability and accuracy of skeletal muscle imaging in limb-girdle muscular dystrophies

(2012) L. ten Dam et al.   NEUROLOGY

Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients

(2012) L. Servais et al.   NEUROMUSCULAR DISORDERS

Does the severity of the LGMD2A phenotype in compound heterozygotes depend on the combination of mutations?

(2011) Amets Sáenz et al.   MUSCLE & NERVE

Clinical and pathological features in 15 Chinese patients with calpainopathy

(2010) Su-Shan Luo et al.   MUSCLE & NERVE

Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy

(2008) T Paternostro-Sluga et al.   JOURNAL OF REHABILITATION MEDICINE